Healthcare provider profile · identity verified

Tony Mitchell Cox, MD

Internal Medicine · HUNTLAND, TN · NPI 1255425450

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	221	67
Levothyroxine Sodium	Levothyroxine Sodium	199	59
Lisinopril	Lisinopril	195	60
Amlodipine Besylate	Amlodipine Besylate	183	59
Losartan Potassium	Losartan Potassium	176	54
Omeprazole	Omeprazole	160	56
Gabapentin	Gabapentin	126	23
Atorvastatin Calcium	Atorvastatin Calcium	114	35
Montelukast Sodium	Montelukast Sodium	112	37
Meloxicam	Meloxicam	107	41
Metformin Hcl	Metformin Hcl	106	38
Pantoprazole Sodium	Pantoprazole Sodium	102	33
Trazodone Hcl	Trazodone Hcl	101	28
Furosemide	Furosemide	87	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	32
Ezetimibe	Ezetimibe	81	29
Albuterol Sulfate Hfa	Albuterol Sulfate	78	38
Fluticasone Propionate	Fluticasone Propionate	78	48
Tamsulosin Hcl	Tamsulosin Hcl	70	25
Ropinirole Hcl	Ropinirole Hcl	65	17
Hydrochlorothiazide	Hydrochlorothiazide	63	18
Clonazepam	Clonazepam	58	suppressed
Metoprolol Succinate	Metoprolol Succinate	57	22
Metoprolol Tartrate	Metoprolol Tartrate	57	23
Vitamin D2	Ergocalciferol (Vitamin D2)	57	26
Duloxetine Hcl	Duloxetine Hcl	56	16
Cefdinir	Cefdinir	55	43
Eliquis	Apixaban	55	13
Escitalopram Oxalate	Escitalopram Oxalate	55	16
Farxiga	Dapagliflozin Propanediol	55	11
Methylprednisolone	Methylprednisolone	54	47
Sertraline Hcl	Sertraline Hcl	54	14
Alprazolam	Alprazolam	53	13
Hydralazine Hcl	Hydralazine Hcl	53	18
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Bupropion Xl	Bupropion Hcl	51	14
Spironolactone	Spironolactone	51	17
Potassium Chloride	Potassium Chloride	47	19
Atenolol	Atenolol	45	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	15
Glimepiride	Glimepiride	43	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	17
Pravastatin Sodium	Pravastatin Sodium	42	15
Simvastatin	Simvastatin	40	12
Sucralfate	Sucralfate	39	12
Carvedilol	Carvedilol	38	12
Clopidogrel	Clopidogrel Bisulfate	34	17
Azithromycin	Azithromycin	31	30
Finasteride	Finasteride	30	11
Prednisone	Prednisone	30	23
Alendronate Sodium	Alendronate Sodium	29	13
Tramadol Hcl	Tramadol Hcl	29	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	20
Warfarin Sodium	Warfarin Sodium	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	17
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Ozempic	Semaglutide	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	18
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	18
Fluconazole	Fluconazole	24	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Mirtazapine	Mirtazapine	24	11
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Glipizide	Glipizide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Nabumetone	Nabumetone	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Valsartan	Valsartan	21	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Folic Acid	Folic Acid	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Ramipril	Ramipril	14	suppressed
Famotidine	Famotidine	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	13	12
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Linzess	Linaclotide	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error